Can this agreement be signed electronically?

Yes. Electronic signatures are legally enforceable in the United States under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted. Ensure intent, consent, attribution, and reliable record retention to meet the ESIGN four-part validity test.

Do I need a Business Associate Agreement (BAA)?

If the agreement grants access to PHI or involves PHI processing, include a BAA that documents HIPAA obligations. A BAA is required for compliance with HIPAA and to define breach notification and security responsibilities.

Is notarization or witness required for execution?

Not typically required for research contracts, but certain institutions or state rules may demand notarization or witnesses for specific instruments. Check institutional policy and state statute before adding such requirements.

What happens if the PI leaves the institution?

Address personnel changes with successor provisions, data custody clauses, and notification obligations so the institution retains continuity of research and compliance responsibilities.

How do we handle amendments or renewals?

Document amendments in writing, signed by authorized representatives. Include an amendment procedure in the original agreement specifying required approvals and effective dates.

How should executed agreements be stored?

Store executed copies in a secure, access-controlled repository with audit logs. Maintain retention in line with federal and institutional requirements and preserve electronic evidence of signatures, timestamps, and audit trails.

Electronic Signature
Templates
Healthcare
Healthcare Biomedical Research Agreement

Healthcare Biomedical Research Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE BIOMEDICAL RESEARCH AGREEMENT

This Biomedical Research Agreement (the Agreement) is entered into between Research Institution: and Participant Name: . The effective date of enrollment will be the date of the Participant's signature below.

Study Information

Study Title Protocol / Identifier Principal Investigator / Contact Sponsor (if applicable) Summary of Procedures

Expected Duration:

Planned Enrollment Window: From to

Participant Information

Participant Full Legal Name

Date of Birth:

Gender:

Participant ID (if assigned):

Address

Phone:

Email:

Emergency Contact

Insurance Information

Primary Insurance Provider

Policy Number:

Group Number:

Subscriber Name (if different)

Medical History

Current Medications Allergies (drug, food, other) Prior Surgeries and Hospitalizations Chronic Conditions

I am pregnant, breastfeeding, or may become pregnant during the study period.

Risks, Benefits, and Alternatives

The Participant has been informed of the purpose, procedures, anticipated duration, potential risks and discomforts, potential benefits, and reasonable alternatives to participation in this research. Known risks and potential side effects have been described by the Investigator. The Participant understands that no guarantee can be made that participation will result in direct medical benefit.

I acknowledge that I have had the opportunity to ask questions about the study and that my questions have been answered to my satisfaction. I have been informed of foreseeable procedures and reasonably foreseeable risks and agree to participate on a voluntary basis.

I acknowledge that I understand the risks and benefits as explained above.

Use of Data and Biospecimens; Confidentiality

The Participant authorizes the collection, storage, use, and disclosure of data and biospecimens obtained in the course of the study for the purposes described in the study summary. Data that identify the Participant will be handled in a manner consistent with applicable privacy protections; however, absolute confidentiality cannot be guaranteed. De-identified data and specimens may be shared with collaborators for future research.

I consent to storage and future use of de-identified biospecimens and data for research related to the study objectives.

I do NOT consent to future use of my biospecimens or data beyond this study (my data will be used only for this study).

Authorization Expiration Date (if applicable)

Compensation and Treatment for Research-Related Injury

The Participant will receive the compensation and reimbursements described below for participation. The Participant understands that the Research Institution will provide information regarding available medical treatment for research-related injury and whether costs will be covered by the study, the Participant's health insurer, or the Participant.

Compensation / Stipend Travel Reimbursement

Withdrawal; Termination

The Participant may withdraw from the study at any time without penalty or loss of benefits to which the Participant is otherwise entitled. The Investigator or Research Institution may withdraw the Participant for reasons including safety, non-compliance, or study termination. The Participant understands the consequences of withdrawal, including how data and specimens already collected may be used.

HIPAA Authorization and Privacy Acknowledgment

By signing below, the Participant authorizes the Research Institution and its agents to use and disclose protected health information as necessary to conduct the research, to monitor safety, and to comply with applicable reporting requirements. The Participant understands that authorization for disclosure is voluntary and can be revoked in writing, except to the extent that action has already been taken.

I authorize release of my protected health information for purposes of this research.

Legal Terms

The Participant understands that: (a) participation is voluntary; (b) refusal to participate or withdrawal will not affect access to routine medical care; (c) the Research Institution, Sponsor, and Investigator shall not be liable for claims arising from non-research related medical care; and (d) the Research Institution may retain ownership rights to data, databases, and discoveries arising from the study. This Agreement is governed by the laws of the jurisdiction where the Research Institution is located.

The Participant agrees to release and hold harmless the Research Institution and Investigator from claims arising solely from participation in the research except for claims resulting from gross negligence or willful misconduct. Nothing in this Agreement limits the Participant's right to seek damages for research-related injury as otherwise provided by applicable law.

Participant Certification

I certify that the Investigator has explained the research, procedures, risks, benefits, and alternatives to me. I have read (or have had read to me) the information provided and have had the opportunity to ask questions. I voluntarily agree to participate in this study under the terms described in this Agreement.

Participant Printed Name:

Relationship to Subject (if signed by guardian/representative):

Signature:

Date Signed:

What the Healthcare Biomedical Research Agreement Is

A Healthcare Biomedical Research Agreement is a legally binding contract that sets the terms for collaborative biomedical research involving healthcare providers, research institutions, sponsors, or vendors. It defines responsibilities for data collection, use and disclosure of protected health information (PHI), intellectual property, publication rights, funding and indemnity, and regulatory compliance such as HIPAA and FDA requirements. The agreement also typically addresses institutional review board (IRB) approvals, data security controls, subcontracting, and termination terms to protect participants and institutions while enabling lawful research activities.

Why a Clear Agreement Matters

A well-drafted Healthcare Biomedical Research Agreement reduces legal and operational risk by clarifying PHI handling, regulatory responsibilities, IP ownership, and liability between parties.

Who Typically Prepares and Signs This Agreement

Ensure the final signatory has delegated authority from the institution and that required approvals (IRB, compliance, grants office) are documented before execution.

Principal Investigators and Research Teams — Draft technical scope, protocols, and data-sharing needs; confirm IRB approvals and research timelines.
Institutional Legal Counsel and Contracts Offices — Review liability, indemnity, IP assignment, and compliance language; negotiate sponsor terms.
Sponsors and CROs — Define funding, milestones, deliverables, and access to results; manage subcontracting and vendor obligations.

Core Elements to Include in the Agreement

A complete agreement balances scientific flexibility with clear legal and compliance provisions so parties can operate confidently while protecting participants and data.

Scope of Work

Describe study objectives, protocol references, deliverables, milestones, and roles so responsibilities and outcomes are unambiguous.

Data Use Terms

Specify categories of data, permitted uses, de-identification standards, data transfer mechanisms, and retention schedules tied to regulatory needs.

PHI Protections

Include HIPAA compliance obligations, required Business Associate Agreement (BAA) language where applicable, and security controls for PHI.

Intellectual Property

Allocate ownership of inventions and background IP, define rights to jointly developed IP, and set procedures for patent filing and revenue sharing.

Regulatory Approvals

Document IRB approvals, informed consent responsibilities, and any required FDA, OHRP, or other agency registrations or notifications.

Liability & Indemnity

Set limits on liability, insurance requirements, indemnification scope, and procedures for breach notification and remediation.

Step-by-Step: How to Complete and Execute the Agreement

Follow these sequential steps to prepare, approve, and execute a legally compliant agreement.

01

Drafting: Populate scope, parties, and key fields using institutional templates and sponsor input.
02

Regulatory Check: Confirm IRB approval status and any required informed-consent language.
03

Legal Review: Contracts office reviews IP, indemnity, and data clauses.
04

Execution: Obtain authorized signatures and date the agreement effective.

How to Configure an Online Signing Workflow

Set up an electronic workflow to streamline routing, authentication, and retention of the signed agreement.

Field	Configuration
Signers and Order	List signers, role order, and alternate signers to ensure correct routing.
Authentication Level	Choose email, SMS code, or stronger methods for sensitive PHI agreements.
Required Fields	Mark required fields (effective date, PI signature, institutional countersignature).
Audit Trail	Enable timestamping, IP capture, and certificate of completion for legal evidence.

Where to Send and File the Finished Agreement

After execution, route copies to institutional offices and maintain a central, access-controlled record for compliance and audits.

Institutional Contracts: Provide a fully executed copy to the contracts office for recordkeeping.
IRB Office: Submit executed agreement to IRB if required by institutional policy.
Sponsor: Send the signed counterpart to the sponsor and retain the confirmation.
Secure Archive: File the final document in a secure repository with restricted access.

Distribution and Delivery Options for Execution

Ensure the chosen channel preserves an audit trail, supports required authentication, and is consistent with institutional policy and HIPAA protections.

Email Link: Quick delivery; suitable for low-risk signers.
SMS Code: Adds a second factor for signer verification.
In-Person or Kiosk: Use when identity must be verified physically or notarization is required.

Key Timelines and Deadlines to Track

Identify and calendar critical dates to avoid compliance gaps, funding delays, or IRB noncompliance.

Effective Date:

Date when payment obligations and data access begin.

IRB Approval Date:

Must precede any human-subjects activity or data collection.

Funding Milestones:

Dates tied to deliverables or payment tranches.

Data Retention Start:

Begins on effective date or data collection completion, whichever applies.

Reporting Deadlines:

Regulatory or sponsor progress reports and final reports.

Common Preparation Mistakes to Avoid

Omitting IRB or consent language creates regulatory exposure and can halt research activities or invalidate data collection.
Vague data-use terms (e.g., 'research purposes') leave parties open to disagreement over re-use, secondary analyses, or sharing.
Failing to require a BAA when PHI is exchanged can breach HIPAA obligations and expose institutions to penalties and remediation costs.
Not aligning signature authority with institutional delegation leads to delayed execution or invalid agreements that require re-signature.

Principal Risks and Legal Consequences

Data Breach: Regulatory fines and remediation costs

Invalid Consent: Research data may be unusable

HIPAA Violation: Civil penalties and corrective action

Breach of Contract: Damages, injunctive relief, termination

IP Dispute: Loss of ownership or licensing claims

Publication Delay: Impact on grants and reputation

Security and Compliance Controls to Specify

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

Audit Trail: Time-stamped logs capturing signer actions

Certifications: SOC 2 Type II and ISO 27001 available

HIPAA Controls: BAA required for PHI handling

21 CFR Part 11: Compliant controls for FDA-regulated records

Access Controls: Role-based permissions and MFA

Frequently Asked Questions and Practical Answers

Answers to common questions about validity, PHI, electronic signatures, and post-execution handling for biomedical research agreements.

Need help? Contact support

Can this agreement be signed electronically?
Yes. Electronic signatures are legally enforceable in the United States under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted. Ensure intent, consent, attribution, and reliable record retention to meet the ESIGN four-part validity test.
Do I need a Business Associate Agreement (BAA)?
If the agreement grants access to PHI or involves PHI processing, include a BAA that documents HIPAA obligations. A BAA is required for compliance with HIPAA and to define breach notification and security responsibilities.
Is notarization or witness required for execution?
Not typically required for research contracts, but certain institutions or state rules may demand notarization or witnesses for specific instruments. Check institutional policy and state statute before adding such requirements.
What happens if the PI leaves the institution?
Address personnel changes with successor provisions, data custody clauses, and notification obligations so the institution retains continuity of research and compliance responsibilities.
How do we handle amendments or renewals?
Document amendments in writing, signed by authorized representatives. Include an amendment procedure in the original agreement specifying required approvals and effective dates.
How should executed agreements be stored?
Store executed copies in a secure, access-controlled repository with audit logs. Maintain retention in line with federal and institutional requirements and preserve electronic evidence of signatures, timestamps, and audit trails.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now